2024
Systemic anti-cancer treatment and healthcare utilization at end of life: A SEER Medicare analysis.
Adelson K, Canavan M, Niu J, Zhao H, Nortje N, Xiang J, Giordano S, Cheng L. Systemic anti-cancer treatment and healthcare utilization at end of life: A SEER Medicare analysis. Journal Of Clinical Oncology 2024, 20: 276-276. DOI: 10.1200/op.2024.20.10_suppl.276.Peer-Reviewed Original ResearchEnd-of-lifeSystemic anticancer therapyDay of deathIntensive care unit useIntensive care unitHealthcare utilizationEmergency departmentCombined chemo-immunotherapyEnd-of-life chemotherapy useAssociated with healthcare utilizationImmunotherapy useChemo-immunotherapyIncreased healthcare useEnd of lifeAdverse quality of lifeAssociated with higher EDCare unitQuality of lifeSystemic anti-cancer treatmentHospice useDay hospiceHospice enrollmentSEER-Medicare databaseUse of chemotherapyHealthcare use
2023
The association between systemic anticancer therapy (SACT) at the end of life (EOL) and acute care use among patients treated at oncology practices participating in the Oncology Care Model (OCM).
Canavan M, Sheth K, Scott J, Westvold S, Adelson K. The association between systemic anticancer therapy (SACT) at the end of life (EOL) and acute care use among patients treated at oncology practices participating in the Oncology Care Model (OCM). Journal Of Clinical Oncology 2023, 41: 6580-6580. DOI: 10.1200/jco.2023.41.16_suppl.6580.Peer-Reviewed Original ResearchSystemic anticancer therapyDay of deathOncology Care ModelEnd of lifeAcute care useIntensive care unitInpatient admissionsED visitsCare useReceipt of chemotherapyAcute care utilizationEmergency department useProportion of decedentsRates of chemotherapyChi-square testICU stayIO therapyCare unitCare utilizationInpatient stayCT patientsDepartment useHospice useCare metricsOncology practice
2020
End-of-life (EOL) trajectories among older adults dying with lung cancer (LC).
Davidoff A, Canavan M, Wang S, Prsic E, Saphire M, Presley C. End-of-life (EOL) trajectories among older adults dying with lung cancer (LC). Journal Of Clinical Oncology 2020, 38: e24008-e24008. DOI: 10.1200/jco.2020.38.15_suppl.e24008.Peer-Reviewed Original ResearchPalliative care servicesHospital referral regionsLung cancerCancer decedentsCare intensityNon-Hispanic whitesCD careLine therapyHospice enrollmentSEER-MedicareIntensive careHospice useOlder decedentsPhysician preferenceHigh riskHospice careMultinomial logistic regressionReferral regionsMedicare decedentsHigher ageCare servicesHealth statusLogistic regressionDecedentsHospice
2016
End-of-Life Care Intensity and Hospice Use
Wang SY, Aldridge MD, Gross CP, Canavan M, Cherlin E, Johnson-Hurzeler R, Bradley E. End-of-Life Care Intensity and Hospice Use. Medical Care 2016, 54: 672-678. PMID: 27111747, PMCID: PMC4907842, DOI: 10.1097/mlr.0000000000000547.Peer-Reviewed Original ResearchConceptsLife care intensityHospital referral regionsShort hospice enrollmentEmergency department useCare intensityHospice useHospice enrollmentDepartment useLife careIntensive care unit admissionOverall hospice useCare unit admissionProportion of decedentsMonths of lifeUnit admissionICU admissionICU daysPatient characteristicsIntensive careLowest quintileReferral regionsIntensive endShort stayAORNumber of days
2015
Has Hospice Use Changed? 2000–2010 Utilization Patterns
Aldridge MD, Canavan M, Cherlin E, Bradley EH. Has Hospice Use Changed? 2000–2010 Utilization Patterns. Medical Care 2015, 53: 95-101. PMID: 25373406, PMCID: PMC4262565, DOI: 10.1097/mlr.0000000000000256.Peer-Reviewed Original ResearchConceptsHospice enrollmentHospice useHospice usersShort hospice enrollmentLong enrollment periodsUtilization patternsDiverse patient populationsCross-sectional analysisHospice disenrollmentHospice referralNoncancer diagnosesMultivariable analysisPatient populationMedicare decedentsEnrollment periodMedicare hospiceHospicePatientsSubstantial proportionHospice characteristicsEnrollmentDeathLonger enrollmentPast decadeReferral